Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.13% | -5.93% | 22.41% | -0.14% | 23.52% |
| Total Depreciation and Amortization | -0.37% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.79% | -46.38% | 10.99% | -38.52% | 167.75% |
| Change in Net Operating Assets | -30.54% | 190.88% | 5.70% | 43.61% | -164.88% |
| Cash from Operations | -25.08% | 21.71% | 22.74% | 6.53% | -10.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 551,100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -650.21% | -100.53% | -- | -- | -- |
| Cash from Financing | 6,347.03% | -100.52% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | 203.69% | -834.48% | -383.33% | -119.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.14% | -274.97% | 134.48% | 6.48% | -32.83% |